Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.21M Buy
+39,480
New +$4.78M 0.05% 608
2025
Q4
Sell
-144,726
Closed -$20.8M 1229
2025
Q3
$20.8M Buy
144,726
+62,802
+77% +$7.69M 0.35% 42
2025
Q2
$8.24M Buy
81,924
+37,500
+84% +$2.87M 0.17% 177
2025
Q1
$3.39M Sell
44,424
-31,330
-41% -$2.4M 0.08% 414
2024
Q4
$5.23M Sell
75,754
-5,747
-7% -$414K 0.12% 274
2024
Q3
$5.95M Sell
81,501
-79,874
-49% -$5.89M 0.16% 189
2024
Q2
$10.8M Buy
161,375
+49,815
+45% +$1.93M 0.36% 31
2024
Q1
$3.03M Buy
+111,560
New +$3.12M 0.12% 292
2023
Q1
Sell
-17,620
Closed -$352K 1216
2022
Q4
$352K Buy
+17,620
New +$341K 0.02% 899

Other funds holding INSM

Algert Global's INSM Position: Q2 2026 in Review

Algert Global opened a new position in Insmed (INSM) in Q2 2026: 39,480 shares worth $4.21M. The stake represents 0.05% of the portfolio and ranks #608 among its holdings. This is a return to the name: Algert Global previously reported a position in INSM as recently as Q3 2025.

Algert Global first reported a position in INSM in Q4 2022 and has held it in 9 quarters since. The position peaked at $20.8M in Q3 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Algert Global held 39,480 shares of Insmed worth $4.21M as of Q2 2026.
  • Insmed was a new Algert Global position in Q2 2026.
  • Insmed made up 0.05% of Algert Global's portfolio in Q2 2026, its #608 holding.
  • Algert Global first reported a position in Insmed in Q4 2022 and has held it in 9 quarters since.
  • Algert Global's Insmed position peaked at $20.8M in Q3 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.